
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Peroxin 10 CRISPR/Cas9 KO Plasmid (h) | sc-406226 | 20 µg | $397.00 |
PEX10 encodes peroxin 10, a RING finger E3 ubiquitin ligase embedded in the peroxisomal membrane that is essential for peroxisome biogenesis and matrix protein import. As part of the peroxisomal ubiquitination machinery with PEX2 and PEX12, PEX10 helps regulate recycling of the PEX5 import receptor and supports peroxisomal metabolic pathways including very-long-chain fatty acid β-oxidation and reactive oxygen species homeostasis. Disruption of PEX10 impairs peroxisome assembly and compromises lipid metabolism and redox balance, processes central to cellular stress responses and organelle crosstalk. Pathogenic variants in PEX10 are linked to peroxisome biogenesis disorders within the Zellweger spectrum, making it a relevant target for studying mechanisms of organelle dysfunction.
Peroxin 10 CRISPR/Cas9 KO Plasmid (h) is a pool of plasmids designed for targeted disruption of the PEX10 gene in human cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the PEX10 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the PEX10 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Peroxin 10 protein expression.
This CRISPR knockout system enables efficient generation of PEX10-deficient cell models for investigation of Peroxin 10 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.